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Myocarditis is a focal or diffuse inflammatory reaction of the myocardium with degeneration or 
necrosis of myocytes, followed by an infiltration of inflammatory cells. Inflammatory myocardial 
disease or myocarditis is not commonly diagnosed in horses but the use of cTnI has markedly 
increased the sensitivity to detect myocardial disease. A wide variety of causes can result in 
myocarditis. The clinical signs, which are related to cardiac electrophysiological and contractile 
properties, and to underlying disease, are very variable. In many cases with clinical signs and 
increased troponin levels indicative of myocardial disease the exact aetiology remains speculative. 
Aetiological factors are of infectious, toxic, nutritional, infiltrative, hyperthermic, hypoxic or 
idiopathic origin. Viral infection, such as Influenza, Equine Viral Arteritis virus, Equine Infectious 
Anaemia, African Horse Sickness, Equine Herpes Virus 1, Eastern Equine Encephalomyelitis, and 
bacterial infection, e.g. Streptococcus spp., Staphylococcus spp., Salmonella, Clostridium, Borrelia 
burgdorferi, piroplasmosis, Leptospirosis, Neorickettsia risticii, and also parasites as Strongylus 
vulgaris, Onchocerca, have been associated with myocarditis. Myocardial inflammation may result 
from exposure to cardiotoxins from plants (foxglove, oleander, Adonis, Eonymus, lily of valley, yew, 
rhododenderon,…), ionophore antibiotics (monensin, salinomycin, lasalocid), heavy metals, 
cantharidin toxicosis (blister beetle), snakebite envenomation,… Nutritional imbalances, such as due 
to vitamin E, selenium, copper and molybdenum, and ischemia and heat stroke may also result in 
myocarditis.  
Clinical signs are very variable and range from subclinical to poor performance, exercise intolerant, 
syncope and sudden death. Clinical signs may be those of underlying systemic disease (fever, colic, 
weakness, respiratory signs, shock,…) or may be directly related to myocardial damage. Myocardial 
inflammation may result in enhanced ectopy or vulnerability, impaired conduction, and altered 
systolic or diastolic function. Enhanced ectopy results in atrial or ventricular premature beats, 
ventricular tachycardia or ventricular fibrillation. Enhanced or, more frequently, decreased 
ventricular contractile function may occur and in chronic cases myocardial fibrosis might be present.  
In order to make a diagnosis, history is very important (duration of disease, possible contact with 
toxins, other animals involved,…). Physical exam may reveal dysrhythmias, a cardiac murmur, weak 
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pulse, oedema. Electrocardiography (ambulatory, exercise, 24-hour) and cardiac ultrasound are 
crucial to evaluate cardiac function. Cardiac glycosides may result in increased inotropy while many 
other toxins will produce contractile dysfunction. Complete blood count and biochemistry including 
cTnI must be performed. In case of suspicion of specific disease or intoxication, serum, urine 
samples, swabs,… should be taken for further diagnostic tests (digoxin, serology, PCR, toxicology,…). 
The environment should be checked for possible contact with toxins (plants, …).  
The horse should be rested for at least 6-8 weeks. Therapy aims to treat underlying disease and life-
threatening dysrhythmias, improve cardiac function and treat heart failure. In case of intoxication, 
further access to the toxin must be avoided and activated charcoal or mineral oil should be 
administered by nasogastric tube in acute cases of oral intoxication. Horses must be closely 
monitored during the treatment. Horses that recover should always be re-examined before they are 
allowed to return to exercise. 
Below an update will be given by describing a number of cases of myocardial injury that were 
encountered over recent years. 
Lasalocid intoxication  
Accidental lasalocid poisoning occurred on a farm with 81 horses, of which 14 started to show clinical 
signs after being fed a new concentrate batch. One horse died on day 20 and another on day 27. The 
most severe cases (n = 7), admitted to the clinic on day 29–46, underwent cardiac examination and 
blood biochemical analysis, including determination of plasma cardiac troponin I (cTnI), at admission 
and during follow-up. On day 57–70, cardiac examination, including TDI and 2D speckle tracking, cTnI 
determination or both were undertaken on 72 remaining horses. Short-term effects of lasalocid 
intoxication included inappetance, lethargy, sweating, and muscular weakness. All 7 horses admitted 
to the clinic demonstrated signs of myocardial degeneration such as increased cTnI (1.39-816 ng/ml), 
dysrhythmia and reduced myocardial contractility. Four horses developed ataxia on day 40–50. Five 
horses died or were euthanized on day 30–370, 2 horses recovered fully and returned to previous 
athletic use. None of the 72 remaining horses exhibited clinical signs between day 57–70, but 34 had 
dysrhythmia and 13 had increased cTnI concentrations. After a period of rest, all these horses 
returned to their previous work. Lasalocid was detected in hepatic tissue of 2 necropsied horses. 
Lasalocid intoxication induced myocardial and neurological damage. Although uncommon, this 
should be included as differential diagnosis for unexplained inappetance, signs of depression, 
cardiomyopathy, and ataxia in horses. TDI and 2DST measurements allowed detection and 
quantification of LV dysfunction in horses exposed to lasalocid. 
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Atypical myopathy 
Atypical myopathy (AM) is an acute, often fatal, rhabdomyolysis in grazing horses that mainly affects 
skeletal muscles. Post mortem examinations have shown that myocardial damage also occurs. 
Limited information is available on the effect of AM on cardiac function in affected and surviving 
horses. Horses (n = 12) diagnosed with AM, in which cardiac ultrasound and ECG recordings was 
obtained, were studied. All horses underwent clinical examination, serum biochemistry, 
electrocardiography, and echocardiography. Four surviving horses underwent the same examinations 
after 2-10 weeks. All but 1 horse had increased cardiac troponin I concentrations and 10 horses had 
ventricular premature depolarizations (VPDs). All horses had prolonged corrected QT (QTcf) intervals 
on the day of admission and abnormal myocardial wall motion on echocardiography. One of the 
surviving horses showed VPDs and prolonged QTcf at follow-up after 10 weeks. It was concluded that 
AM resulted in characteristic electrocardiographic and echocardiographic changes and that it was 
commonly associated with increased cardiac troponin I concentrations and VPDs. In survivors, 
abnormal cardiac function may be found at follow-up after 10 weeks. Additional research in a larger 
group of horses is necessary to identify the long-term effects of AM on cardiac function. 
Other cases 
Additional cases will be presented such as cardiac glycoside intoxication, resulting in ventricular 
arrhythmia, increased inotropy and/or atrial standstill, suspected iron intoxication with advanced 
second degree atrioventricular block, and infra-hisian block probably due to lyme disease.  
